Emerging research suggest Retatrutide , a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could offer a significant development for obesity management . https://crossbookmark.com/story21295015/the-retatru-tide-peptide-the-breakthrough-in-physique-control